PRESENTATION TITLE

Viruses to the Rescue:  Discovering, Translating and Commercially Developing Mayo's Anticancer Viruses


PRESENTER(S)

Stephen J. Russell, M.B.Ch.B., Ph.D., FRCP (UK), FRCPaugh (UK), LLD (Hon.), Consultant, Department of Molecular Medicine, Consultant, Division of Hematology, Department of Internal Medicine, Professor of Medicine, Mayo Clinic, Rochester, Minnesota

PRESENTER BIO

Stephen J. Russell MD PhD, Founder, Director, CEO & President

Dr. Russell is a Professor of Molecular Medicine, Consultant Hematologist at Mayo Clinic Rochester and serves on the Board of Trustees of Buena Vista University, Iowa. He obtained his MD from the University of Edinburgh, Scotland and his PhD from the University of London, England. He trained at University College Hospital and the Royal Marsden Hospital, London, then moved to Cambridge, England where he led a research team in the MRC Laboratory for Molecular Biology and was a practicing consultant hematologist at Addenbrooke’s Hospital. In 1998 he moved to Mayo Clinic where he built a comprehensive translational gene and virus therapy program, established the Department of Molecular Medicine, developed innovative technologies for targeting viruses to cancer cells, and orchestrated the first-in-human testing of oncolytic Measles and Vesicular stomatitis viruses. In addition to his academic faculty role, he is currently serving as CEO of Vyriad, an oncolytic virotherapy company. 

His research is focused on developing engineered viruses for the treatment of disseminated malignancies and demonstrating their efficacy in clinical trials.  Research themes in his laboratory include the engineering of viral membrane glycoproteins, targeting cell to cell fusion, targeting virus entry, using cellular microRNAs to reprogram virus tropism, modulating and exploiting virus-tumor-immune system interactions, pharmacokinetic and pharmacodynamic studies of virus-based therapies, noninvasive monitoring and imaging of viral gene expression in vivo, and radiovirotherapy. 

VIEWING LOCATIONS
Zoom Registration Link

LEARNING OBJECTIVES

• Identify five characteristics of the digital health care system of 2030.
• Enumerate three examples of how platform approaches will improve health care experiences for both patients and providers.
• Describe initiatives designed to increase transparency and reduce bias in artificial intelligence.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.